Exzolt
fluralaner
Table of contents
Overview
This is a summary of the European public assessment report (EPAR) for Exzolt.It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Exzolt.
For practical information about using Exzolt, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Authorisation details
Product details | |
---|---|
Name |
Exzolt
|
Agency product number |
EMEA/V/C/004344
|
Active substance |
fluralaner
|
International non-proprietary name (INN) or common name |
fluralaner
|
Species |
Chicken
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QP53BE02
|
Publication details | |
---|---|
Marketing-authorisation holder |
Intervet International B.V.
|
Revision |
3
|
Date of issue of marketing authorisation valid throughout the European Union |
18/08/2017
|
Contact address |
Wim de Körverstraat 35 |
Product information
22/12/2021 Exzolt - EMEA/V/C/004344 - IB-0013
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Ectoparaciticides, insecticides and repellents
Therapeutic indication
Treatment of poultry red mite (Dermanyssus gallinae) infestation in pullets, breeders and layer hens.